Literature DB >> 18762851

Eu-estrogenemia, WHI, timing and the "geripause".

Ralph J Turner, Irwin J Kerber.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18762851     DOI： 10.1007/s00192-008-0708-6

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


× No keyword cloud information.
  14 in total

1.  Eu-estrogenemia.

Authors:  I J Kerber; R J Turner
Journal:  J Appl Physiol (1985)       Date:  2005-12

2.  Ageing of the female pelvic floor: towards treatment a la carte of the "geripause".

Authors:  Diaa E E Rizk; Mohamed A Fahim
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-02-15

3.  Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.

Authors:  Peter P Zandi; Michelle C Carlson; Brenda L Plassman; Kathleen A Welsh-Bohmer; Lawrence S Mayer; David C Steffens; John C S Breitner
Journal:  JAMA       Date:  2002-11-06       Impact factor: 56.272

4.  Effects of estrogen with and without progestin on urinary incontinence.

Authors:  Susan L Hendrix; Barbara B Cochrane; Ingrid E Nygaard; Victoria L Handa; Vanessa M Barnabei; Cheryl Iglesia; Aaron Aragaki; Michelle J Naughton; Robert B Wallace; S Gene McNeeley
Journal:  JAMA       Date:  2005-02-23       Impact factor: 56.272

5.  Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis.

Authors:  Howard N Hodis; Wendy J Mack; Donna Shoupe; Stanley P Azen; Frank Z Stanczyk; Juliana Hwang-Levine; Matthew J Budoff; Victor W Henderson
Journal:  Menopause       Date:  2015-04       Impact factor: 2.953

6.  Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions.

Authors:  Shotaro Suzuki; Candice M Brown; Christopher D Dela Cruz; Enhua Yang; David A Bridwell; Phyllis M Wise
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-26       Impact factor: 11.205

7.  Postmenopausal hormone therapy: does it cause incontinence?

Authors:  Jody E Steinauer; L Elaine Waetjen; Eric Vittinghoff; Leslee L Subak; Stephen B Hulley; Deborah Grady; Feng Lin; Jeanette S Brown
Journal:  Obstet Gynecol       Date:  2005-11       Impact factor: 7.661

8.  27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen.

Authors:  Michihisa Umetani; Hideharu Domoto; Andrew K Gormley; Ivan S Yuhanna; Carolyn L Cummins; Norman B Javitt; Kenneth S Korach; Philip W Shaul; David J Mangelsdorf
Journal:  Nat Med       Date:  2007-09-16       Impact factor: 53.440

Review 9.  Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression.

Authors:  Thomas B Clarkson
Journal:  Menopause       Date:  2007 May-Jun       Impact factor: 3.310

10.  Estrogen and neuroprotection: from clinical observations to molecular mechanisms.

Authors:  Dena B Dubal; Phyllis M Wise
Journal:  Dialogues Clin Neurosci       Date:  2002-06       Impact factor: 5.986
View more
  1 in total

Review 1.  A theory of eu-estrogenemia: a unifying concept.

Authors:  Ralph J Turner; Irwin J Kerber
Journal:  Menopause       Date:  2017-09       Impact factor: 2.953
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.